14/05/2008
ReGen Therapeutics Plc (‘ReGen’ or the ‘Company’ AIM: RGT) announces that Percy Lomax Chairman and Chief Executive of ReGen has been invited to present at the Rodman & Renshaw 5th Annual Global Healthcare Conference at 2.20pm on Tuesday 20 May 2008.
This Conference is a major showcase for industry to present to Global Biotech Investors. In the presentation Percy Lomax will be assisted by Dr Marian Kruzel ReGen’s Chief Scientific Officer.
A copy of the presentation will be available on the Company’s website www.regentherapeutics.com simultaneously on Tuesday 20 May 2008.
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel No 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish
Tel No 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel No 020 7448 9800
Adrian Duffield/Jon Davies
College Hill Associates
Tel No 020 7457 2020
Notes for Editors:
Rodman & Renshaw is a full service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. It also provides research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Services include:
Investment Banking
Research
Sales & Trading
Conferences
Rodman & Renshaw Biotech Conference (338KB PDF)